Back to Insights

Why 80% of Healthcare Executives Believe AI Will Transform Care, But Most Have Not Deployed It Yet

Author

Fornex Health Team

Published

June 10, 2026

AI Transforming Healthcare Care

The belief is not the problem. More than 80% of health system and health plan executives believe generative AI along with agentic AI will deliver moderate-to-significant value across clinical and business operations in 2026. CMS

NVIDIA's 2026 healthcare AI survey reveals adoption jumped to 70% from 63%, with 85% of executives reporting revenue gains along with nearly half planning 10%+ budget increases. Protiviti

Those numbers look impressive. Then you look at what "adoption" actually means in practice.

Only 25% of respondents have moved at least 40% of their AI experiments into production environments. Nearly three in four companies plan to deploy agentic AI within the next two years, up from 23% today. Governance remains a gap, with only about 20% of organizations reporting mature frameworks for managing AI agents. Lexogrine

Healthcare is enthusiastic about AI. Healthcare is not particularly good at shipping it. The gap between those two facts is the most important operational challenge in health IT right now.

Why the Gap Exists

The honest answer is that deploying AI in healthcare is harder than deploying AI anywhere else. The data is fragmented across systems that were not designed to talk to each other. The regulatory environment adds compliance requirements that do not exist in other industries. The stakes when something goes wrong are measured in patient outcomes, not just revenue.

76% of business leaders reported difficulties with AI deployment in 2024 citing strategy gaps, data quality, along with team readiness. 56% of companies highlighted data quality as a major barrier. Gartner predicts organizations will abandon 60% of AI projects unsupported by AI-ready data. mexc

In healthcare specifically, data quality problems are structural. Patient data exists in EHRs, in payer systems, in imaging platforms, in RPM devices, in patient-reported outcomes tools. Most of that data is not standardized. Most of those systems do not share data in real time. An AI system that needs a complete, current view of a patient to function well often cannot get one because the data infrastructure was never built to provide it.

This is the gap between believing in AI and being able to deploy it. Belief does not require clean data. Deployment does.

Where Healthcare AI Is Actually Working Right Now

The use cases that have made it to production share common characteristics. The data inputs are structured along with consistent. The outputs are verifiable by humans. The failure modes are contained rather than cascading.

Healthcare is leading AI agent adoption with 68% already using AI agents. Four in ten healthcare executives already use AI for inpatient monitoring along with early warnings about patient health issues. This area is expected to see full implementation of agentic AI within three years. Digital Applied Team

Administrative workflows dominate. Prior authorization processing. Eligibility verification. Appointment scheduling. Denial management. These are areas where the data is relatively structured, the payer rules are defined, along with the cost of an AI error - while not trivial - is recoverable through appeals processes.

Clinical workflows are further behind. Not because the technology cannot support clinical applications. It can, increasingly well. The barrier is governance. Before an AI system influences a clinical decision, your organization needs to know how it was validated, on what patient population, with what ongoing monitoring in place. Organizations must validate AI tools within their specific deployment context before clinical implementation. This requirement is non-negotiable along with ongoing. Spectrum

The organizations moving fastest are not trying to do everything at once. They are picking one workflow, deploying it properly, measuring results, then expanding. That sounds obvious. Most organizations are not doing it.

The Governance Gap Is the Production Gap

Only 10% of healthcare organizations utilize automated product monitoring to detect AI capabilities. The majority rely on informal ad hoc discovery along with vendor release notes. Elarafy

74% plan to deploy agentic AI within two years yet only 21% say they have a mature governance model.

Those two statistics are related. Organizations without governance frameworks cannot safely deploy AI in production. They know it. So they keep things in pilot indefinitely. The pilot becomes the permanent state. The board presentation says "AI strategy in progress." The clinical operations look the same as they did two years ago.

Governance is not the obstacle to AI deployment. The absence of governance is the obstacle to AI deployment. Building a real governance framework - BAAs with every AI vendor, audit trails for AI outputs, local validation protocols, staff training on appropriate AI use is what unlocks the ability to move from pilot to production.

The organizations that are moving fastest on AI in 2026 are not the ones with the most AI enthusiasm at the executive level. They are the ones that invested in governance infrastructure 12 to 18 months ago along with are now reaping the ability to deploy with confidence.

What the Laggards Are Getting Wrong

There are three patterns that consistently separate organizations stuck in pilot from organizations that have shipped.

  • Waiting for the technology to mature. The technology is mature enough for well-defined administrative workflows right now. The organizations waiting for a better version are ceding ground to competitors who are building institutional knowledge through actual deployment experience. You learn more from 90 days of live operation than from 12 months of evaluating demos.
  • Piloting without a production pathway. A pilot without a defined success criteria along with a clear production decision process is not a pilot. It is a delay mechanism with better optics. Before you start any AI pilot, define the metrics that would trigger a production decision along with the metrics that would trigger a decision to stop.
  • Underinvesting in data infrastructure. Organizations will abandon 60% of AI projects unsupported by AI-ready data. The AI project budget should include a data infrastructure line item. Cleaning patient records, building FHIR-compliant API connections, establishing real-time data feeds between clinical systems - these are not separate from AI deployment. They are prerequisites for it. mexc

The Organizations That Will Win

Organizations seeing 5x to 10x returns on their AI agent investments report a 42% reduction in documentation time for healthcare providers. Those returns are real. They come from organizations that treated AI deployment as an operational discipline, not a technology experiment.

The health systems that will have significant AI advantages in 2028 are building three things right now. Clean, interoperable data infrastructure. Governance frameworks that can absorb new AI deployments without starting from scratch each time. Institutional knowledge about what works in their specific clinical along with operational environment.

None of those things come from watching. They come from deploying, measuring, learning, along with iterating.

The belief that AI will transform healthcare is almost universal now. The willingness to do the unglamorous infrastructure work that makes transformation possible is much rarer. That gap is where the competitive advantage actually lives in 2026.

For a practical view of what AI agent deployment looks like in the revenue cycle context specifically, our blog on what hospitals get wrong when deploying AI agents in revenue cycle covers the most common mistakes along with how to avoid them.

Fornex Health helps healthcare organizations move from AI pilot to production - with data infrastructure, governance frameworks, along with workflow integration built for clinical environments. Talk to our team.